Form 4: Molina Healthcare Executive Jeff D. Barlow Reports Stock Transactions
SEC Form 4
Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
Summary
- Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, filed a Form 4 detailing changes in beneficial ownership.
- On March 1, 2025, Barlow acquired 7,882 shares of common stock at $301.12 related to performance stock units that vested at 149% of target.
- Also on March 1, 2025, 4,221 and 1,851 shares were disposed of to cover withholding taxes related to vesting.
- Barlow also acquired 4,859 shares of restricted stock at $288.12 under the 2019 Equity Incentive Plan.
- Following these transactions, Barlow beneficially owns 72,817 shares of Molina Healthcare common stock.
- The restricted stock grant vests in one-third increments on March 1, 2026, March 1, 2027, and March 1, 2028.
Sentiment
Score: 7
Explanation: The document indicates positive performance as the performance stock units vested at 149% of the target. The insider is maintaining a significant holding in the company.
Positives
- The vesting of performance stock units at 149% suggests strong company performance relative to targets.
Future Outlook
The document outlines the vesting schedule for the restricted stock, indicating future equity compensation for the reporting person.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding management's holdings and activities in the company's stock.
Comparison to Industry Standards
- Equity compensation practices, such as performance stock units and restricted stock grants, are common in the healthcare industry to align management's interests with those of shareholders.
- Vesting schedules and performance metrics are typically designed to incentivize long-term value creation.
- The vesting of performance stock units at 149% suggests that Molina Healthcare exceeded its performance targets, which is a positive indicator compared to industry peers.
Stakeholder Impact
- Shareholders may view the vesting of performance stock units at 149% as a positive sign of company performance.
- Employees may be motivated by the achievement of performance targets and the associated equity compensation.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Date of grant for the performance stock units that vested on March 1, 2025. |
| March 1, 2025 | Date of stock transactions: acquisition of shares from performance stock units, disposal for tax withholding, and grant of restricted stock. |
| February 28, 2025 | Closing price of Molina Healthcare's common stock used for valuation of performance stock units. |
| March 1, 2026 | First vesting date for one-third of the newly granted restricted stock (4,859 shares) and 2,563 additional shares. |
| March 1, 2027 | Second vesting date for one-third of the newly granted restricted stock (4,859 shares) and 1,102 additional shares. |
| March 1, 2028 | Final vesting date for one-third of the newly granted restricted stock (4,859 shares). |
| March 4, 2025 | Date of filing the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.